Clinical trial Recruiting at 1 site Observational Ages 18 to 65

Long-term outcomes of the Mosaic mitral valve in patients under 65

Official title: Long Term Patient Outcomes and Product Durability of the Mosaic Mitral Valve Bioprosthesis in Patients Under 65

Run by ProMedica Health System · NCT06917586 · Data updated 2026-11-12

This study looks at how well the Mosaic mitral valve works over time in people under 65 who have had valve replacement surgery.

More Heart Valve Diseases trials

Quick facts

Study typeObservational
Ages18 Years to 65 Years
SexAll
Enrollment300 (estimated)
SponsorProMedica Health System
Academic / other
Locations1 site (Toledo, Ohio)
StatusRecruiting
StartedJanuary 1, 2025
Main results expectedJuly 1, 2026
Study endsJuly 1, 2027
Registry record updatedFebruary 20, 2026
Trial IDNCT06917586 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients under 65 years old who have received the Mosaic mitral valve bioprosthetic at ProMedica Toledo Hospital.

Probably not a fit

Patients over the age of 65 or those who had their surgery performed at institutions other than ProMedica Toledo Hospital may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the long-term efficacy and stability of the Mosaic bioprosthetic mitral valve in patients under the age of 65 who have undergone valve replacement at ProMedica Toledo Hospital. It aims to assess patient outcomes, including the incidence of structural valve deterioration and overall performance of the valve. The study addresses a gap in existing literature regarding younger patients, as most research has focused on older populations. By analyzing these outcomes, the study seeks to provide valuable insights into the durability and effectiveness of this specific valve type in a younger demographic.

Why it matters

Potential benefit: If successful, this study could provide critical information on the long-term performance of the Mosaic mitral valve, potentially improving treatment decisions for younger patients with valve disease.

How similar studies have gone: While studies have documented the efficacy of bioprosthetic valves in older populations, this specific focus on younger patients with the Mosaic mitral valve is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Received the Mosaic Mitral Valve Bioprosthetic at ProMedica Toledo Hospital
* Under the age of 65

Exclusion Criteria:

* Over the age of 65
* Under the age of 18
* Surgery performed at institutions outside of ProMedica Toledo Hospital

Where it's running

  • ProMedica Toledo Hospital
    Toledo, Ohio, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.